Multitarget 2'-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities.
Kamecki F, Knez D, Carvalho D, Marcucci C, Rademacher M, Higgs J, Žakelj S, Marcos A, de Tezanos Pinto F, Abin-Carriquiry JA, Gobec S, Colettis N, Marder M.
Kamecki F, et al. Among authors: de tezanos pinto f.
Neuropharmacology. 2021 Dec 15;201:108837. doi: 10.1016/j.neuropharm.2021.108837. Epub 2021 Oct 12.
Neuropharmacology. 2021.
PMID: 34653442